|
|
Apply to become an ESCMID Local Champion
|
To strengthen ESCMID's collaboration with local/regional societies and to increase international outreach, the society is establishing a network of Local Champions, who will be advocates for ESCMID in the broadest sense.
We accept applications from all countries, except for Albania, Austria, Bulgaria, Colombia, Croatia, Cyprus, Czech Republic, France, Italy, Lithuania, Pakistan, Poland, Republic of Korea, North Macedonia, Romania, Sweden, Switzerland, Turkey, United Kingdom, Ukraine (which were covered in a previous call to ESCMID Affiliated Societies).
Deadline for applications is on 28 November 2024.
|
|
|
|
|
|
|
|
|
|
Science & Research
|
|
Join us tomorrow for the third part of the new ESCMID AMR webinar series
|
Taking place tomorrow Wednesday, 13 November 2024 at 15:30 – 16:30 CET, join the third webinar of the 4-part webinar series organised by the ESCMID AMR Action Subcommittee in the lead up to World AMR Awareness Week 2024. The third part will focus on the latest strategies in antibiotic development.
See the full programme and details on the rest of the series on their website!
|
|
|
|
Applications for the CAREer Grant are now open
|
The CAREer Grant supports members balancing scientific careers with family responsibilities (childcare) or unexpected situations (illness, caring for elderly parents, etc.). It provides financial assistance to hire qualified support personnel for members who need to reduce their workload or are already working part-time.
Find out more details on our website.
|
|
|
Education
|
|
Elevate your ER expertise in infection control and antimicrobial stewardship!
|
In the fast-paced ER environment, timely and precise infection control and antimicrobial decisions are crucial. This immersive module, designed for ER professionals - including doctors, nurses, pharmacists, and infection control teams - will empower you with the best practices for patient safety, screening, isolation, and antimicrobial selection. Our simulation-based approach ensures you’re prepared to apply these skills in real-time, high-stakes settings.
This course is part of the ESCMID EUCIC Certificate Programme.
|
|
|
|
Join this ESCMID Course on AMS in migration- and travel-associated infections!
|
Join us to explore the global impact of climate change and mobility on infectious disease management. This course empowers healthcare professionals to diagnose and treat infections linked to travel and migration, with a holistic focus on medical, cultural, and political factors. Learn to apply antimicrobial stewardship (AMS) in real-world contexts, addressing health issues influenced by migration, One Health, and climate change.
This course is part of the ESCMID AMS Certificate Programme.
|
|
|
Congress & Events
|
|
Preliminary programme available for the Education Friday at ESCMID Global 2025
|
ESCMID Global is extending the programme with a full day dedicated solely to education. It will feature 6 separate tracks with a total of 30 sessions and various workshops that will also introduce new learning formats in addition to the established ones you already know.
|
|
|
|
Preliminary programme available for IMMEM XIV
|
Check out the IMMEM XIV preliminary programme, offering extensive learning opportunities through lectures, panel discussions, plenary, debate and bioinformatics sessions.
Stay tuned on our website for regular updates on the conference.
|
|
|
Guidelines & Journals
|
|
Launching a new series that reexamines old studies underpinning current practice recommendations
|
The editorial team at CMI Communications invites you to submit your commentary describing an old study/studies whose impact has been greater than would be allowed by today's methodologic standards
|
|
|
|
|
Impact of Pseudomonas aeruginosa carriage on ICU-acquired pneumonia: a European multicentre prospective cohort study
|
|
|
Oral vancomycin prophylaxis for the prevention of recurrent Clostridioides difficile infection during re-exposure to systemic antibiotics: A systematic review and meta-analysis
|
|
|
International regulators have published a report highlighting their considerations on the development, clinical trials and availability of vaccines and therapeutics for mpox. The report presents the outcomes of a workshop that was organised by EMA under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA)
|
|
|